Copyright Reports & Markets. All rights reserved.

Global and United States Metastatic Colorectal Cancer Surgery Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Metastatic Colorectal Cancer Surgery Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Tumor Resection
    • 1.2.3 Portal Vein Embolization
  • 1.3 Market by Application
    • 1.3.1 Global Metastatic Colorectal Cancer Surgery Market Share by Application: 2020 VS 2026
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
    • 1.3.4 Cancer Research Centers
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Metastatic Colorectal Cancer Surgery Market Perspective (2015-2026)
  • 2.2 Global Metastatic Colorectal Cancer Surgery Growth Trends by Regions
    • 2.2.1 Metastatic Colorectal Cancer Surgery Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Metastatic Colorectal Cancer Surgery Historic Market Share by Regions (2015-2020)
    • 2.2.3 Metastatic Colorectal Cancer Surgery Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Metastatic Colorectal Cancer Surgery Players by Market Size
    • 3.1.1 Global Top Metastatic Colorectal Cancer Surgery Players by Revenue (2015-2020)
    • 3.1.2 Global Metastatic Colorectal Cancer Surgery Revenue Market Share by Players (2015-2020)
  • 3.2 Global Metastatic Colorectal Cancer Surgery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Metastatic Colorectal Cancer Surgery Revenue
  • 3.4 Global Metastatic Colorectal Cancer Surgery Market Concentration Ratio
    • 3.4.1 Global Metastatic Colorectal Cancer Surgery Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Metastatic Colorectal Cancer Surgery Revenue in 2019
  • 3.5 Key Players Metastatic Colorectal Cancer Surgery Area Served
  • 3.6 Key Players Metastatic Colorectal Cancer Surgery Product Solution and Service
  • 3.7 Date of Enter into Metastatic Colorectal Cancer Surgery Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Metastatic Colorectal Cancer Surgery Breakdown Data by Type (2015-2026)

  • 4.1 Global Metastatic Colorectal Cancer Surgery Historic Market Size by Type (2015-2020)
  • 4.2 Global Metastatic Colorectal Cancer Surgery Forecasted Market Size by Type (2021-2026)

5 Metastatic Colorectal Cancer Surgery Breakdown Data by Application (2015-2026)

  • 5.1 Global Metastatic Colorectal Cancer Surgery Historic Market Size by Application (2015-2020)
  • 5.2 Global Metastatic Colorectal Cancer Surgery Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Metastatic Colorectal Cancer Surgery Market Size (2015-2026)
  • 6.2 North America Metastatic Colorectal Cancer Surgery Market Size by Type (2015-2020)
  • 6.3 North America Metastatic Colorectal Cancer Surgery Market Size by Application (2015-2020)
  • 6.4 North America Metastatic Colorectal Cancer Surgery Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Metastatic Colorectal Cancer Surgery Market Size (2015-2026)
  • 7.2 Europe Metastatic Colorectal Cancer Surgery Market Size by Type (2015-2020)
  • 7.3 Europe Metastatic Colorectal Cancer Surgery Market Size by Application (2015-2020)
  • 7.4 Europe Metastatic Colorectal Cancer Surgery Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Metastatic Colorectal Cancer Surgery Market Size (2015-2026)
  • 8.2 China Metastatic Colorectal Cancer Surgery Market Size by Type (2015-2020)
  • 8.3 China Metastatic Colorectal Cancer Surgery Market Size by Application (2015-2020)
  • 8.4 China Metastatic Colorectal Cancer Surgery Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Metastatic Colorectal Cancer Surgery Market Size (2015-2026)
  • 9.2 Japan Metastatic Colorectal Cancer Surgery Market Size by Type (2015-2020)
  • 9.3 Japan Metastatic Colorectal Cancer Surgery Market Size by Application (2015-2020)
  • 9.4 Japan Metastatic Colorectal Cancer Surgery Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Metastatic Colorectal Cancer Surgery Market Size (2015-2026)
  • 10.2 Southeast Asia Metastatic Colorectal Cancer Surgery Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Metastatic Colorectal Cancer Surgery Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Metastatic Colorectal Cancer Surgery Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Sanofi
    • 11.1.1 Sanofi Company Details
    • 11.1.2 Sanofi Business Overview
    • 11.1.3 Sanofi Metastatic Colorectal Cancer Surgery Introduction
    • 11.1.4 Sanofi Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020))
    • 11.1.5 Sanofi Recent Development
  • 11.2 Roche
    • 11.2.1 Roche Company Details
    • 11.2.2 Roche Business Overview
    • 11.2.3 Roche Metastatic Colorectal Cancer Surgery Introduction
    • 11.2.4 Roche Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020)
    • 11.2.5 Roche Recent Development
  • 11.3 Eli Lilly
    • 11.3.1 Eli Lilly Company Details
    • 11.3.2 Eli Lilly Business Overview
    • 11.3.3 Eli Lilly Metastatic Colorectal Cancer Surgery Introduction
    • 11.3.4 Eli Lilly Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020)
    • 11.3.5 Eli Lilly Recent Development
  • 11.4 Pfizer
    • 11.4.1 Pfizer Company Details
    • 11.4.2 Pfizer Business Overview
    • 11.4.3 Pfizer Metastatic Colorectal Cancer Surgery Introduction
    • 11.4.4 Pfizer Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020)
    • 11.4.5 Pfizer Recent Development
  • 11.5 Novartis
    • 11.5.1 Novartis Company Details
    • 11.5.2 Novartis Business Overview
    • 11.5.3 Novartis Metastatic Colorectal Cancer Surgery Introduction
    • 11.5.4 Novartis Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020)
    • 11.5.5 Novartis Recent Development
  • 11.6 Amgen
    • 11.6.1 Amgen Company Details
    • 11.6.2 Amgen Business Overview
    • 11.6.3 Amgen Metastatic Colorectal Cancer Surgery Introduction
    • 11.6.4 Amgen Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020)
    • 11.6.5 Amgen Recent Development
  • 11.7 Taiho Oncology
    • 11.7.1 Taiho Oncology Company Details
    • 11.7.2 Taiho Oncology Business Overview
    • 11.7.3 Taiho Oncology Metastatic Colorectal Cancer Surgery Introduction
    • 11.7.4 Taiho Oncology Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020)
    • 11.7.5 Taiho Oncology Recent Development
  • 11.8 Genentech
    • 11.8.1 Genentech Company Details
    • 11.8.2 Genentech Business Overview
    • 11.8.3 Genentech Metastatic Colorectal Cancer Surgery Introduction
    • 11.8.4 Genentech Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020)
    • 11.8.5 Genentech Recent Development
  • 11.9 EMD Serono
    • 11.9.1 EMD Serono Company Details
    • 11.9.2 EMD Serono Business Overview
    • 11.9.3 EMD Serono Metastatic Colorectal Cancer Surgery Introduction
    • 11.9.4 EMD Serono Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020)
    • 11.9.5 EMD Serono Recent Development
  • 11.10 Suzhou Zelgen Biopharmaceuticals
    • 11.10.1 Suzhou Zelgen Biopharmaceuticals Company Details
    • 11.10.2 Suzhou Zelgen Biopharmaceuticals Business Overview
    • 11.10.3 Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Surgery Introduction
    • 11.10.4 Suzhou Zelgen Biopharmaceuticals Revenue in Metastatic Colorectal Cancer Surgery Business (2015-2020)
    • 11.10.5 Suzhou Zelgen Biopharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Metastatic Colorectal Cancer Surgery Scope and Market Size
    Metastatic Colorectal Cancer Surgery market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Metastatic Colorectal Cancer Surgery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Tumor Resection
    Portal Vein Embolization

    Market segment by Application, split into
    Hospitals
    Clinics
    Cancer Research Centers

    Based on regional and country-level analysis, the Metastatic Colorectal Cancer Surgery market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Metastatic Colorectal Cancer Surgery market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Sanofi
    Roche
    Eli Lilly
    Pfizer
    Novartis
    Amgen
    Taiho Oncology
    Genentech
    EMD Serono
    Suzhou Zelgen Biopharmaceuticals

    Buy now